Literature DB >> 16365392

Hydrolytic and nonenzymatic functions of acetylcholinesterase comodulate hemopoietic stress responses.

Dan Grisaru1, Marjorie Pick, Chava Perry, Ella H Sklan, Ronit Almog, Ilan Goldberg, Elizabeth Naparstek, Joseph B Lessing, Hermona Soreq, Varda Deutsch.   

Abstract

Glucocorticoid-initiated granulocytosis, excessive proliferation of granulocytes, persists after cortisol levels are lowered, suggesting the involvement of additional stress mediator(s). In this study, we report that the stress-induced acetylcholinesterase variant, AChE-R, and its cleavable, cell-penetrating C-terminal peptide, ARP, facilitate granulocytosis. In postdelivery patients, AChE-R-expressing granulocyte counts increased concomitantly with serum cortisol and AChE activity levels, yet persisted after cortisol had declined. Ex vivo, mononuclear cells of adult peripheral blood responded to synthetic ARP26 by overproduction of hemopoietically active proinflammatory cytokines (e.g., IL-6, IL-10, and TNF-alpha). Physiologically relevant ARP26)levels promoted AChE gene expression and induced the expansion of cultured CD34+ progenitors and granulocyte maturation more effectively than cortisol, suggesting autoregulatory prolongation of ARP effects. In vivo, transgenic mice overexpressing human AChE-R, unlike matched controls, showed enhanced expression of the myelopoietic transcription factor PU.1 and maintained a stable granulocytic state following bacterial LPS exposure. AChE-R accumulation and the consequent inflammatory consequences can thus modulate immune responses to stress stimuli.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16365392     DOI: 10.4049/jimmunol.176.1.27

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

1.  Butyrylcholinesterase attenuates amyloid fibril formation in vitro.

Authors:  Sophia Diamant; Erez Podoly; Assaf Friedler; Hagai Ligumsky; Oded Livnah; Hermona Soreq
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-26       Impact factor: 11.205

2.  Decline in serum cholinesterase activities predicts 2-year major adverse cardiac events.

Authors:  Yaron Arbel; Shani Shenhar-Tsarfaty; Nir Waiskopf; Ariel Finkelstein; Amir Halkin; Miri Revivo; Shlomo Berliner; Itzhak Herz; Itzhak Shapira; Gad Keren; Hermona Soreq; Shmuel Banai
Journal:  Mol Med       Date:  2014-02-12       Impact factor: 6.354

3.  Acetylcholinesterase protein level is preserved in the Alzheimer's brain.

Authors:  María-Letizia Campanari; María-Salud García-Ayllón; Lidia Blazquez-Llorca; Wilson K W Luk; Karl Tsim; Javier Sáez-Valero
Journal:  J Mol Neurosci       Date:  2013-12-07       Impact factor: 3.444

4.  AChE and RACK1 promote the anti-inflammatory properties of fluoxetine.

Authors:  Nir Waiskopf; Keren Ofek; Adi Gilboa-Geffen; Uriya Bekenstein; Assaf Bahat; Estelle R Bennett; Erez Podoly; Oded Livnah; Gunther Hartmann; Hermona Soreq
Journal:  J Mol Neurosci       Date:  2013-11-21       Impact factor: 3.444

5.  Plant-derived human acetylcholinesterase-R provides protection from lethal organophosphate poisoning and its chronic aftermath.

Authors:  Tama Evron; Brian C Geyer; Irene Cherni; Mrinalini Muralidharan; Jacquelyn Kilbourne; Samuel P Fletcher; Hermona Soreq; Tsafrir S Mor
Journal:  FASEB J       Date:  2007-05-02       Impact factor: 5.191

6.  Cholinergic status modulations in human volunteers under acute inflammation.

Authors:  Keren Ofek; Karen S Krabbe; Tama Evron; Meir Debecco; Anders R Nielsen; Helle Brunnsgaad; Raz Yirmiya; Hermona Soreq; Bente K Pedersen
Journal:  J Mol Med (Berl)       Date:  2007-07-27       Impact factor: 4.599

7.  Hematological parameters and hair mercury levels in adolescents from the Colombian Caribbean.

Authors:  Alejandra Manjarres-Suarez; Jesus Olivero-Verbel
Journal:  Environ Sci Pollut Res Int       Date:  2020-02-10       Impact factor: 4.223

8.  Age-dependent modulation of fasting and long-term dietary restriction on acetylcholinesterase in non-neuronal tissues of mice.

Authors:  Kitlangki Suchiang; Ramesh Sharma
Journal:  Mol Cell Biochem       Date:  2016-07-05       Impact factor: 3.396

9.  Different cholinesterase inhibitor effects on CSF cholinesterases in Alzheimer patients.

Authors:  Agneta Nordberg; Taher Darreh-Shori; Elaine Peskind; Hilkka Soininen; Malahat Mousavi; Gina Eagle; Roger Lane
Journal:  Curr Alzheimer Res       Date:  2009-02       Impact factor: 3.498

10.  Increased Expression of Readthrough Acetylcholinesterase Variants in the Brains of Alzheimer's Disease Patients.

Authors:  Maria-Letizia Campanari; Francisco Navarrete; Stephen D Ginsberg; Jorge Manzanares; Javier Sáez-Valero; María-Salud García-Ayllón
Journal:  J Alzheimers Dis       Date:  2016-05-30       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.